Allergy Treatment Shots: What the Multi-Year Course Actually Involves
Allergy treatment shots means subcutaneous immunotherapy (SCIT) — the 3-to-5-year therapeutic procedure of escalating allergen extract injections per Cox 2011 PP3. The 'treatment' framing signals the searcher understands the multi-year commitment and wants procedural detail. Year 1 involves approximately 39 clinic visits. Cochrane 2007: symptom SMD -0.73. Durham 1999 NEJM: 3-year course produces 4-year durable remission. Indicated for allergic rhinitis, asthma, and Hymenoptera venom allergy with confirmed IgE sensitization.
6 peer-reviewed sources
Allergy treatment shots are SCIT — a 3-5 year subcutaneous allergen extract course requiring ~39 clinic visits in Year 1. The only disease-modifying allergy treatment per Cox/Murphey/Hankin 2020. Cochrane 2007: symptom SMD -0.73.
The essentials
Allergy treatment shots map directly to subcutaneous immunotherapy (SCIT) in clinical terminology. The 'treatment' modifier distinguishes therapeutic SCIT from non-therapeutic injections (diagnostic skin testing, depot corticosteroids) and positions SCIT correctly as a multi-year therapeutic course rather than a single-visit intervention.
The treatment-course architecture of SCIT consists of two phases per Cox 2011 PP3 (JACI 2011;127[1 Suppl]:S1-S55). The build-up phase spans approximately 4-6 months with weekly injections, escalating from 1,000- to 10,000-fold below the maintenance dose across approximately 26-28 visits. Combined with approximately 13 early-maintenance visits (every 2-4 weeks), Year 1 involves approximately 39 total clinic visits. The maintenance phase then continues every 2-4 weeks for a total course of 3-5 years. A mandatory 30-minute post-injection observation period applies to every single visit, making each appointment approximately 45 minutes total and the cumulative clinic time approximately 110 hours for a 3-year course.
Indications for allergy treatment shots per Cox 2011 PP3 include: allergic rhinitis and/or conjunctivitis with documented IgE sensitization to a treatable aeroallergen and inadequate symptom control on pharmacotherapy; allergic asthma meeting spirometric criteria; and Hymenoptera venom allergy (bee, wasp, hornet, yellow jacket). Contraindications include uncontrolled asthma (FEV1 <70% predicted on day of injection), concurrent beta-blocker use (relative contraindication), and pregnancy initiation (continuation of established maintenance is generally acceptable per Cox 2011).
Curex pairs at-home IgE testing with board-certified allergist review to identify the specific allergens that should be included in any treatment regimen — the diagnostic step that precedes Cox 2011 SCIT extract preparation.
The evidence base for allergy treatment shots is robust. Calderón MA et al (Cochrane Database Syst Rev 2007, DOI 10.1002/14651858.CD001936.pub2) analyzed 51 RCTs with 2,871 patients, finding symptom-score SMD -0.73 (95% CI -0.97 to -0.50) and medication-score SMD -0.57 in favor of SCIT. Durham SR et al (NEJM 1999;341:468-475) established that a 3-year course produces 4 additional years of durable post-treatment remission. Cox L, Murphey A, and Hankin C (Immunol Allergy Clin North Am 2020;40[1]:69-85, PMID 31761122) confirmed that SCIT is the only disease-modifying allergy treatment with long-term remission documented in randomized trials.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
Allergy treatment shots follow a standardized protocol with three distinct phases. Understanding the visit frequency and duration upfront significantly improves adherence.
Doses escalate from 1,000- to 10,000-fold below maintenance over 26-28 weekly injections. A mandatory 30-minute post-injection observation period applies at every visit. Cluster protocols (2-3 injections per visit) can compress build-up to 4-8 weeks (Tabar 2005 JACI) but require more time per visit.
Once the therapeutic maintenance dose is reached, frequency drops and immune consolidation occurs. The 30-minute observation requirement continues. Dose adjustments are required if gaps exceed 3-4 months.
After 3-5 year course completion, no further injections typically needed. Durham 1999 NEJM documented 4-year durable benefit post-discontinuation; observational follow-up suggests 7-12+ years for many patients.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Within the category of treatment shots, patients may encounter SCIT, subcutaneous biologics (Xolair, Dupixent), and depot corticosteroids — all delivered by injection but serving fundamentally different clinical purposes.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
SCIT (allergy treatment shots — disease-modifying) | |||||
SLIT drops (same treatment goal, no injections) | |||||
Xolair (omalizumab — ongoing biologic) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients ready for the multi-year disease-modifying course but not for weekly in-clinic injections, Curex delivers the allergy treatment shot itself at home: a personalized SCIT serum sterile-compounded to USP <797> standards, prescribed and overseen by a board-certified allergist and self-administered as one weekly shot at home for $129/month. The first dose and every dose change are supervised live over Zoom and a prescribed epinephrine auto-injector is confirmed on hand — the same Treg-induction, disease-modifying course, without the clinic-visit schedule, for eligible patients.
See if at-home shots are right for youFrequently asked questions
Who qualifies for allergy treatment shots?
Allergy treatment shots (SCIT) are indicated for patients with allergic rhinitis, allergic conjunctivitis, or allergic asthma with documented IgE sensitization to a treatable aeroallergen and inadequate symptom control on pharmacotherapy; and for patients with Hymenoptera venom allergy (bee, wasp, hornet, yellow jacket). Per Cox 2011 PP3, contraindications include uncontrolled asthma (FEV1 below 70% predicted), concurrent beta-blocker use (relative), severe cardiovascular disease, and pregnancy initiation. SCIT is supported for children aged 5 years and older. Patients whose allergy testing shows sensitization to untreatable allergens (cockroach, per the failed CRITICAL 2024 trial) may not benefit from SCIT.
How long do allergy treatment shots take to start working?
Most patients receiving SCIT notice meaningful symptom improvement within 3-6 months of reaching the maintenance dose — typically after completing the 6-month build-up phase and the first few months of maintenance. The AAAAI/ACAAI Practice Parameter recommends that 12 full months at maintenance be completed before effectiveness is assessed, because benefits accumulate progressively across the course. Initial partial improvements may be apparent during late build-up. Full disease-modifying benefits require completing the entire 3-5 year course per Durham SR et al (NEJM 1999) and Cox 2011 PP3.
What is the difference between allergy treatment shots and allergy shots?
Allergy treatment shots and allergy shots refer to the same procedure — subcutaneous immunotherapy (SCIT). The 'treatment' modifier in 'allergy treatment shots' emphasizes the multi-year therapeutic course nature of the procedure as distinct from single-visit or symptomatic injections. Clinically there is no difference: both phrases describe the same 3-to-5-year allergen extract injection course defined in Cox 2011 PP3, billed under CPT 95115/95117 (injection administration) and 95165 (extract preparation).
Are allergy treatment shots dangerous?
Allergy treatment shots are given in a physician's office specifically because of the small but real risk of systemic allergic reactions. Local injection-site reactions (redness, swelling, itching) occur in approximately 20-70% of patients and are expected. Systemic reactions (generalized hives, mild wheezing, sneezing) occur in approximately 0.1% of injection visits per Epstein TG et al (Ann Allergy Asthma Immunol 2013/2014). Fatal reactions are extremely rare — one fatality per 23.3 million injection visits in the 2008-2012 surveillance period. The most significant risk factor for serious reactions is uncontrolled asthma: patients with FEV1 below 70% predicted should not receive injections on that day. The 30-minute observation period is the most critical safety measure.
Can allergy treatment shots be done faster?
Cluster immunotherapy protocols can compress the build-up phase from 26-28 weeks to 4-8 weeks by administering 2-4 injections per clinic visit at increasing doses (Tabar AI et al, JACI 2005). Rush immunotherapy reaches maintenance in 1-3 days under close supervision with premedication (Bernstein DI et al, JACI 2008 — systemic reaction rates 5-15%). Ultra-rush protocols (hours) are primarily used for Hymenoptera venom immunotherapy only. The trade-off for faster build-up is higher systemic reaction rates per visit — cluster has a moderately increased risk; rush protocols require hospital or clinic settings with emergency resources. Maintenance frequency (every 2-4 weeks for 3-5 years) cannot be meaningfully compressed.
Do allergy treatment shots work for asthma?
SCIT is FDA-recognized for allergic asthma in patients with documented IgE sensitization to relevant aeroallergens. The Cochrane asthma immunotherapy meta-analysis (Abramson MJ et al, Cochrane 2010) found SCIT reduces asthma symptom scores and medication use. The PAT study (Jacobsen L et al, Allergy 2007) showed that SCIT in allergic-rhinitis children reduced subsequent asthma development by approximately half at 10-year follow-up. The most critical safety consideration for asthma patients: those with poorly controlled asthma (FEV1 <70% predicted) must not receive injections on that day, because uncontrolled asthma is the strongest risk factor for fatal reactions per the Cox 2011 PP3 safety guidelines.
Related Articles
Allergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreDesensitization Allergy: SCIT Guide & Mechanism | Curex
Desensitization for allergy means SCIT — a 3-to-5-year dose-escalation course inducing immune tolerance. Cochrane 51 RCTs: SMD -0.73. Distinct from acute drug desensitization.
Read moreAllergy Shot Medication: SCIT vs Biologics vs Steroids | Curex
Allergy shot medication (SCIT) is allergen extract — FDA CBER, not CDER. No branded SCIT product. Greer, ALK, HollisterStier supply extracts. Custom-mixed per patient. Durham 1999 remission.
Read moreAllergy Shot For Humans: SCIT & SLIT Guide
Yes, there is an allergy shot for humans — subcutaneous immunotherapy (SCIT). Cochrane SMD −0.73, 3–5 yr course, at home via Curex $129/mo. Not Cytopoint.
Read moreSeasonal Allergy Shots Schedule & Count | Curex Guide
Seasonal allergy shots total 60–80 injections over 3–5 years. Cox 2011: 39 Year-1 visits. Learn the schedule mechanics and why adherence drops after visit one.
Read moreAllergy Therapy: All Treatments Explained | Curex
Allergy therapy spans pharmacotherapy, SCIT shots, SLIT drops, and biologics. Only SCIT and SLIT modify the underlying disease. Learn which therapy fits your situation.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.